Start with a thyroid review, not a weight-loss drug. Hashimoto’s thyroiditis can lead to hypothyroidism, which can affect body weight, but weight changes also have many other causes. A clinician can review thyroid control, symptoms, medicines, and health risks before discussing a weight-management plan 1 2.
What Chia costs, all in.
One monthly price covers the medication, your provider and shipping. No membership fee, no insurance needed.

Tirzepatide tablets
Once a day, no needles
2 months for 1from$249/mo

Tirzepatide injection
Once a week
from$299/mo

Semaglutide injection
Once a week
from$249/mo
New patient offer
Your first 2 months of tablets for $249 $498
Same day prescription
State-licensed pharmacies
US-licensed physicians
FSA/HSA eligible
Tirzepatide tablets, compounded by a licensed 503A pharmacy; not FDA-approved. Prescription only, after a provider’s review; full refund if you are not approved. $249 is the first payment for your first 2 months. Then $498 every 2 months for the rest of the 6-month plan, unless you cancel.
What should I know first about Hashimoto’s and weight loss?
Hashimoto’s thyroiditis is an autoimmune condition that can damage the thyroid over time. When that damage causes low thyroid hormone, called hypothyroidism, metabolism can slow and weight may rise. The amount of weight change varies and is not enough to diagnose the cause on its own 1.
A thyroid diagnosis does not mean weight loss is impossible. It does mean that thyroid-specific care and body-weight management should be considered together. The American Thyroid Association recommends using thyroid-stimulating hormone, or TSH, as a key tool for monitoring primary hypothyroidism 1.
A medication marketed for weight loss does not replace thyroid evaluation. Thyroid hormone treatment is intended to correct hormone deficiency when a clinician diagnoses it; guidelines do not support using thyroid hormone solely as a weight-loss medicine 1 2.
What should be evaluated when weight changes happen with Hashimoto’s?
A weight review with Hashimoto’s should look beyond the number on the scale. TSH and thyroid hormone testing can help a clinician judge whether hypothyroidism is adequately managed, while a broader history can identify other contributors to weight change 1 2.
- Current thyroid diagnosis, past lab results, and thyroid medication history.
- Symptoms such as persistent fatigue, feeling unusually cold, constipation, palpitations, or major changes in sleep or mood.
- Other medicines, including medicines that can affect appetite, fluid balance, or body weight.
- Eating patterns, alcohol use, activity, sleep, stress, and access to regular meals.
- Other health conditions that can influence weight or affect medication safety.
Seek prompt medical care for chest pain, fainting, severe shortness of breath, confusion, or a rapidly worsening condition. New neck swelling, trouble swallowing, or persistent voice changes also deserve clinical evaluation rather than self-treatment 1.
For a closer look at symptoms that can overlap with thyroid problems, see our guide to thyroid dysfunction symptoms. Symptoms alone cannot confirm whether thyroid hormone levels are the cause 1.
What approaches may be part of a weight-management plan?
Weight management works best as a long-term plan, not a short-term correction. Sustainable eating and activity changes are the foundation, while a clinician can help address medical contributors and decide whether prescription treatment fits 2 3.
In a 68-week trial, adults with obesity who received lifestyle counseling plus semaglutide lost more weight on average than those receiving placebo plus lifestyle counseling. The study tested an FDA-approved semaglutide product, not a compounded formulation, and individual results vary 4.
Lifestyle support still matters when medication is used. In clinical trials, participants received regular nutrition and physical-activity counseling alongside study medication, so trial results do not show what medication alone can do 3 4.
If insulin resistance or prediabetes is part of the picture, it can be useful to discuss that separately with a clinician. Our article on losing weight with insulin resistance explains the role of food patterns, movement, sleep, and medical care.
Which next step fits your situation?
The sensible next step depends on what a clinician finds. No single option fits everyone with Hashimoto’s, because thyroid status, health history, goals, and medication risks differ 1 2.
| Your situation | A sensible next step | Important trade-off |
|---|---|---|
| New or worsening symptoms, or no recent thyroid review | Schedule a thyroid and general health review before changing a weight plan. | Symptoms and weight changes can have more than one cause. |
| Thyroid levels are not at the clinician-set target | Review thyroid treatment adherence, timing, interactions, and follow-up testing with the prescriber. | Do not start, stop, or adjust thyroid medicine on your own 1. |
| Thyroid status is stable but weight remains a concern | Discuss nutrition, activity, sleep, health conditions, and prescription options when appropriate. | No plan can promise a specific amount of weight loss 2 3. |
| Considering a GLP-1-based medicine | Review personal and family history, current medicines, expected benefits, side effects, and monitoring. | These medicines are not treatment for Hashimoto’s thyroiditis 6 7. |
Can GLP-1-based weight-loss treatment be considered with Hashimoto’s?
GLP-1-based treatment may be considered for some people with stable thyroid care, but Hashimoto’s alone does not answer whether it is appropriate. A prescribing clinician should review the thyroid diagnosis, current medicines, medical history, and labeled warnings before making that decision 1 6 7.
Wegovy is a brand name for semaglutide, a GLP-1 receptor agonist. Ozempic also contains semaglutide but has different FDA-approved uses. Zepbound and Mounjaro contain tirzepatide, a dual glucose-dependent insulinotropic polypeptide, or GIP, and GLP-1 receptor agonist; they are not interchangeable treatment plans 6 7.
In the 68-week STEP 1 trial, participants receiving 2.4 mg semaglutide once weekly lost an average of 14.9% of baseline body weight, compared with 2.4% with placebo. Nausea, diarrhea, vomiting, and constipation were common, and people with certain personal or family thyroid-cancer histories should not use labeled semaglutide products 4 6.
In the 72-week SURMOUNT-1 trial, participants receiving 15 mg tirzepatide once weekly lost an average of 20.9% of baseline body weight, compared with 3.1% with placebo. Gastrointestinal side effects were common, and the labeled product carries important contraindications and warnings that require individual review 5 7.
Those trial findings describe the active ingredients in the studied FDA-approved products. They do not establish results for compounded semaglutide or compounded tirzepatide, which do not have FDA-evaluated outcomes data 4 5 8.
3-min quiz
Talk through your weight-management options
If weight management is a concern after thyroid care is reviewed, you can start Chia’s online eligibility process. A licensed provider decides whether any prescription is clinically appropriate; a prescription is not guaranteed. Chia medications are compounded by US state-licensed 503A pharmacies, and compounded medications are not FDA-approved. See semaglutide options or tirzepatide options.
How are Hashimoto’s and weight-loss medications evaluated at Chia?
At Chia, Hashimoto’s remains a thyroid-care question, not something our GLP-1 options claim to treat. Our licensed providers review your health questionnaire online and may consider weight-management treatment only when it is clinically appropriate; eligibility and a prescription are never guaranteed.
For eligible patients, we offer compounded semaglutide as an injection. We offer compounded tirzepatide as tablets or an injection. Microdosing plans are available for both treatments, with dosing guided and adjusted by the prescribing provider.
| Chia treatment | Available form | Current starting price |
|---|---|---|
| Compounded semaglutide | Injection | Plans currently start at $249/month. |
| Compounded tirzepatide | Tablets or injection | Tablet plans currently start at $249/month; injection plans currently start at $299/month. |
When a provider prescribes, medications are compounded in the United States by state-licensed 503A compounding pharmacies and shipped to your door. You can message your care team through the patient portal between visits. For a broader comparison of medicines, read our GLP-1 weight-loss guide.
You can begin with the eligibility quiz. If you use an AI agent for care navigation, DoctorMCP is also available at mcp.chia.health to help direct you to Chia’s clinician-reviewed pathway.
What should I ask a clinician before pursuing weight-loss treatment?
Bring your thyroid history and your goals to the visit. A clear medication and symptom review helps a clinician weigh possible benefits against side effects, interactions, and reasons a treatment may not fit 1 6 7.
- Are my recent thyroid tests and symptoms consistent with adequately managed hypothyroidism?
- Could another medicine, health condition, sleep issue, or eating pattern be affecting my weight?
- What benefits are realistic for my health situation, and how will progress be monitored?
- What side effects should prompt a call to the care team?
- Do I have a personal or family history that affects whether a GLP-1-based medicine is appropriate?
- If a compounded medicine is discussed, which licensed 503A pharmacy will compound it and what follow-up is included?
Online care can be appropriate for some weight-management evaluations, but it does not replace urgent in-person care. Our guide to getting weight-loss medication online explains why a real medical review matters.
Frequently asked questions about Hashimoto’s and weight loss
Yes. Chia uses an online health questionnaire followed by licensed-provider review. The provider determines whether treatment is clinically appropriate, and a prescription is never guaranteed.
No. Do not stop or change thyroid medication without the clinician who prescribes it. Your clinician may decide when thyroid testing or medication review is needed.
3-min quiz
Start with a clinician-reviewed evaluation
Chia can evaluate whether compounded semaglutide or compounded tirzepatide fits your weight-management goals after reviewing your health history. A medical evaluation is required, and a prescription is not guaranteed. Medications are compounded by US state-licensed 503A pharmacies; compounded medications are not FDA-approved.
References
- 1.Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014.
- 2.Garber JR, Cobin RH, Gharib H, et al. Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocrine Practice. 2012.
- 3.Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021.
- 4.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
- 5.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
- 6.U.S. Food and Drug Administration. Wegovy (semaglutide) prescribing information. 2025.
- 7.U.S. Food and Drug Administration. Zepbound (tirzepatide) prescribing information. 2025.
- 8.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. 2025.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.


